Birdwatch Note
2023-01-21 04:35:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The individual risk of “vaccine associated myocarditis” (VAM) in the general population is between 0.002% and 0.004%, depending on vaccine. Even among the highest risk subpopulation of teenage males, the individual risk of VAM is approximately 0.011%. https://www.acc.org/latest-in-cardiology/articles/2022/02/09/12/56/vaccine-associated-myocarditis-risk-in-context https://www.cmaj.ca/content/194/45/E1529
Written by 325FE4B7C54E886C6423D6AAFE84039EE72958CFFE59451E6FEC545788B914D2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1616249150248452099
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1616655625009741824
- noteId - 1616655625009741824
- participantId - 325FE4B7C54E886C6423D6AAFE84039EE72958CFFE59451E6FEC545788B914D2
- noteAuthorParticipantId -
- createdAtMillis - 1674275711669
- tweetId - 1616249150248452099
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The individual risk of “vaccine associated myocarditis” (VAM) in the general population is between 0.002% and 0.004%, depending on vaccine. Even among the highest risk subpopulation of teenage males, the individual risk of VAM is approximately 0.011%. https://www.acc.org/latest-in-cardiology/articles/2022/02/09/12/56/vaccine-associated-myocarditis-risk-in-context https://www.cmaj.ca/content/194/45/E1529
Note Ratings
rated at | rated by | |
2023-01-20 23:44:10 -0600 | 04CF5F8796A05E73A6D9C4C349E65BA6427994DF49C7FFA2E1EA5787881659F3 | Rating Details |
2023-01-21 05:18:10 -0600 | 0833B19437BCEB79B86EC36D4CBACF990FD44FEF0EF24F4258E451FA2F5F8442 | Rating Details |
2023-01-20 22:50:40 -0600 | 17122229B41CE746760D69339A59004AB8F0344A355EB88B7BA27D1959A988AB | Rating Details |
2023-01-21 07:16:22 -0600 | 1B657B4B920A5EF764E8BF7D263A5D519D70563D3E5781C67C13DE218B9B5A64 | Rating Details |
2023-01-20 23:15:59 -0600 | 1D1AF325FDA7159A4E78BCBE6269062269E2F069E1839EBE05D0164501ACD0C7 | Rating Details |
2023-01-21 10:32:05 -0600 | 1E63C4F17963B9C5B4489BFDF29FE99946F4AFDBE9F44C5F9A9F6119EB7A78A4 | Rating Details |
2023-01-21 03:22:06 -0600 | 207840202143212E67E0F37DB818B3F5D5B4ADE75654460C10C2C510453A7324 | Rating Details |
2023-01-21 01:39:26 -0600 | 31A871715770F30DF9D90A0B7CECD8ACD5F3B78E6081D8ECB11FDEA06ADF36FC | Rating Details |
2023-01-21 03:48:00 -0600 | 3A631CF5FD50307F8E148F6FFA31D371FD630CCC10564B17E20B01B8C7C872F8 | Rating Details |
2023-01-21 10:30:19 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
2023-01-20 23:54:47 -0600 | 4721277D9A85FE53E4D00FCA752E084F16D707771CC4D883B271774693811677 | Rating Details |
2023-01-21 11:01:05 -0600 | 58315A371465429D1F19A86FB136556057E1E88CD64150D6194D39356970AEAA | Rating Details |
2023-01-21 00:53:24 -0600 | 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 | Rating Details |
2023-01-21 07:29:16 -0600 | 5FB1C8DD98CD9035B0FE7A6B332D3E74F4F1AE9E39BE568A6CD5FB7125DA4C5D | Rating Details |
2023-01-21 00:53:29 -0600 | 6546515D0ED74F02D040A3080A0F510EECC9A8B8487B129BE7D019B2763F3A3D | Rating Details |
2023-01-21 18:00:27 -0600 | 6D1D45E5263A9DDD3915166AF291C972F1CCB3F96FA149D42D04785143F1F56E | Rating Details |
2023-01-21 06:58:15 -0600 | 6E9BA51F5C2274F9527999F1C5CA438A6911C5EF3FBB1314412C3D1F556E3A41 | Rating Details |
2023-01-21 14:01:57 -0600 | 70C181B24233FF8251A370E67F314FF2678F046BCC2BD211A42D44AC787BC7DC | Rating Details |
2023-01-21 08:11:59 -0600 | 71EB268E7A8F69DFC819CAAE0A760DFD1B895A145E18F142043E0C9900DB4061 | Rating Details |
2023-01-21 10:48:02 -0600 | 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C | Rating Details |
2023-01-24 18:04:20 -0600 | 7540386F3FE618CACFEB03754A5305E788486A6D15598F8A3BECFB93EEF18160 | Rating Details |
2023-01-21 06:50:28 -0600 | 78E4E59E18DE505ED7319DEBF4D0E42043C9562CF10B78B474F423186014516D | Rating Details |
2023-01-21 09:09:58 -0600 | 7D7CB7E0C4AD5725255BDA22521CE0B47034844C74D9BFE057A948265CEA04ED | Rating Details |
2023-01-20 22:45:13 -0600 | 873F3C7468C0790B61E29ECBA910F835731B69126F882CF1F21456FC66F41E7B | Rating Details |
2023-01-20 23:11:59 -0600 | 91ED1050C69AB445CFA549CAAF55F48AAC56D267EAADDF024A57D453A99233C4 | Rating Details |
2023-01-24 22:51:49 -0600 | 93BC76D0B2B42D81AC185DFBE58C20769F1E24BF3ADACD7718B27E11DF6437F7 | Rating Details |
2023-01-22 19:42:01 -0600 | 9C46594DA3BD0515B53647F892CCC7C885B3157576399CA803FCB113AAE2DD01 | Rating Details |
2023-01-21 01:13:22 -0600 | A5E6BB1B1D9ACCAB54508A945078EF726C7A75F5EE6D0EED00119EA237D84676 | Rating Details |
2023-01-24 20:39:15 -0600 | A7BDB8341F03991245551AF9F99A6888BDFFE1C6ABE346F2BCBBEEC096B54401 | Rating Details |
2023-01-21 16:52:49 -0600 | AB465CA1F3AA15CE72433F9AE21516C2DEF53A5D11B2F2AB229037579530AFD5 | Rating Details |
2023-01-26 19:25:03 -0600 | B1C440B733748EDA75E16E5BC85D831581B932E8EEE1EAD4726291719A7CB178 | Rating Details |
2023-01-21 15:24:04 -0600 | B1C5C2AFA728FEA2FB000676C4042D8A4B1414189951660003FAB89BECD98269 | Rating Details |
2023-01-21 13:35:25 -0600 | B33BD153C0ECA8E432F71F1066697329FFAE739B61DDFD60A7966AAC5DCC03EC | Rating Details |
2023-01-21 08:29:35 -0600 | B3F75A38C7B7161100450BC24DB0D017C482FD679732EC692F27479971F660D4 | Rating Details |
2023-01-21 07:34:35 -0600 | B7A764681ADF6E316D7D617BADB53F2D5CA3DAEBB2070FF74D4DA2B8EA280692 | Rating Details |
2023-01-22 05:13:26 -0600 | BB4456660854E9918BA50DF763BC559E97BEA09A053E033E0E664E946D27C030 | Rating Details |
2023-01-21 11:04:30 -0600 | BD7DE896C6CF0FE1BE941045DFE99E24D9C13FA49C2ECF94A472FFB72CE7BB43 | Rating Details |
2023-01-21 13:08:12 -0600 | C6C17EFBC10F7AC88365584CC677096625D167F5F46ED8C3EBBBD7EEF7369491 | Rating Details |
2023-01-20 22:54:03 -0600 | C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B | Rating Details |
2023-01-21 18:21:30 -0600 | CBA172B1A9DDD1D441CC406C9B5A86649F3276EF6010807F0D6014186A3E9F9A | Rating Details |
2023-01-21 14:04:50 -0600 | CE5C3CF79F78C5672AA0048EABEA38383B9BA5B4056FD6A65A6FF4D2E2F1FDE2 | Rating Details |
2023-01-20 22:56:48 -0600 | D45A2C2D0A01452EB4CAC563989CA4D4828760FB2A92310BCB8E87CE1A83E5A9 | Rating Details |
2023-01-21 09:52:26 -0600 | EF8B0549E52874BCBC8FD5BCC5B0F7D992C9AF8E3291CF3BB597C6D5C5E21452 | Rating Details |
2023-01-21 06:40:18 -0600 | F28FE2F88AE30E16C479804CF673EDAEC960AC8B7CE4A33D2CA1DF2D06BA3258 | Rating Details |
2023-01-20 23:54:47 -0600 | Rating Details | |
2023-01-20 22:54:03 -0600 | Rating Details | |
2023-01-21 09:09:58 -0600 | Rating Details | |
2023-01-20 23:11:59 -0600 | Rating Details | |
2023-01-21 10:32:05 -0600 | Rating Details | |
2023-01-21 10:30:19 -0600 | Rating Details | |
2023-01-21 06:40:18 -0600 | Rating Details | |
2023-01-26 19:25:03 -0600 | Rating Details | |
2023-01-21 00:53:29 -0600 | Rating Details | |
2023-01-21 07:34:35 -0600 | Rating Details | |
2023-01-21 14:01:57 -0600 | Rating Details | |
2023-01-24 22:51:49 -0600 | Rating Details | |
2023-01-21 16:52:49 -0600 | Rating Details | |
2023-01-20 22:56:48 -0600 | Rating Details | |
2023-01-21 15:24:04 -0600 | Rating Details | |
2023-01-20 23:44:10 -0600 | Rating Details | |
2023-01-21 14:04:50 -0600 | Rating Details | |
2023-01-21 13:35:25 -0600 | Rating Details | |
2023-01-24 20:39:15 -0600 | Rating Details | |
2023-01-21 06:50:28 -0600 | Rating Details | |
2023-01-21 18:21:30 -0600 | Rating Details | |
2023-01-21 08:29:35 -0600 | Rating Details | |
2023-01-20 22:45:13 -0600 | Rating Details | |
2023-01-21 09:52:26 -0600 | Rating Details | |
2023-01-21 01:13:22 -0600 | Rating Details | |
2023-01-22 19:42:01 -0600 | Rating Details | |
2023-01-21 13:08:12 -0600 | Rating Details | |
2023-01-20 22:50:40 -0600 | Rating Details | |
2023-01-24 18:04:20 -0600 | Rating Details | |
2023-01-21 05:18:10 -0600 | Rating Details | |
2023-01-22 05:13:26 -0600 | Rating Details | |
2023-01-21 10:48:02 -0600 | Rating Details | |
2023-01-21 03:48:00 -0600 | Rating Details | |
2023-01-21 11:01:05 -0600 | Rating Details | |
2023-01-21 07:16:22 -0600 | Rating Details | |
2023-01-21 06:58:15 -0600 | Rating Details | |
2023-01-21 11:04:30 -0600 | Rating Details | |
2023-01-21 18:00:27 -0600 | Rating Details | |
2023-01-21 00:53:24 -0600 | Rating Details | |
2023-01-21 03:22:06 -0600 | Rating Details | |
2023-01-20 23:15:59 -0600 | Rating Details | |
2023-01-21 07:29:16 -0600 | Rating Details | |
2023-01-21 01:39:26 -0600 | Rating Details |